APAC Biotech

APAC Biotech Pvt Ltd is a biotechnology company dedicated to dendritic cell-based immunotherapy for the treatment of solid tumors. The company began operations in 2010, and within a short span of six years, it has become a leading biotechnology firm in India engaged in cell-based therapy. APAC Biotech has become synonymous with dendritic cell therapy in the country. The company's personalized dendritic cell-based immunotherapy, APCEDEN®, is the first of its kind to receive recognition and approval from India’s health regulatory authorities.